All Pharma News
CIRM Funds CAR-T NXC-201 US AL Amyloidosis Trial

CIRM Funds CAR-T NXC-201 US AL Amyloidosis Trial
GLOBENEWSWIRE
24 Jul 2024
Share Share
Addex’s Partner Discontinues ADX71149 development in Epilepsy

Addex’s Partner Discontinues ADX71149 development in Epilepsy
GLOBENEWSWIRE
22 Jul 2024
Share Share
Addex Presents Positive Results From GABAB PAM Cough Program At 13th LICS

Addex Presents Positive Results From GABAB PAM Cough Program At 13th LICS
GLOBENEWSWIRE
15 Jul 2024
Share Share
Addex To Present At 13th London International Cough Symposium

Addex To Present At 13th London International Cough Symposium
GLOBENEWSWIRE
12 Jul 2024
Share Share
Addex Shareholders Approve All Resolutions at Annual General Meeting

Addex Shareholders Approve All Resolutions at Annual General Meeting
GLOBENEWSWIRE
01 Jul 2024
Share Share
Addex Reports Q1 2024 Financials, Provides Corporate Update

Addex Reports Q1 2024 Financials, Provides Corporate Update
GLOBENEWSWIRE
06 Jun 2024
Share Share
Addex Convenes Annual General Meeting 2024

Addex Convenes Annual General Meeting 2024
GLOBENEWSWIRE
05 Jun 2024
Share Share
Addex To Report Q1 2024 Results And Host Call On June 6

Addex To Report Q1 2024 Results And Host Call On June 6
GLOBENEWSWIRE
30 May 2024
Share Share
Addex`s Janssen-partnered epilepsy drug fails phase 2 trial

Addex`s Janssen-partnered epilepsy drug fails phase 2 trial
James Waldron FIERCE BIOTECH
29 Apr 2024
Share Share
Addex Provides Update on ADX71149 Phase 2 Epilepsy Study

Addex Provides Update on ADX71149 Phase 2 Epilepsy Study
GLOBENEWSWIRE
29 Apr 2024
Share Share